University of Minnesota

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).

966 total trials 180 currently recruiting 671 completed early-phase tilt top decile by trial count

University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.

University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.

Top-decile sponsor footprint

University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

966 total, page 8 of 20

COMPLETED NA

UNITE Study (UMN-GE) for COVID-19

NCT04701489

TERMINATED NA

Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder

NCT04495673

COMPLETED Phase 3

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

NCT04510194

COMPLETED NA

YouTube-Delivered Physical Activity Intervention

NCT04499547

COMPLETED NA

Standardized Patients to Measure and Address Intersectional Stigma

NCT04896216

TERMINATED NA

Effects of Music Based Intervention (MBI) on Pain Response and Neurodevelopment in Preterm Infants

NCT04286269

COMPLETED NA

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

NCT04578912

COMPLETED NA

Non-Invasive Brain Stimulation to Control Large-Scale Brain Networks

NCT04680481

COMPLETED NA

Preparing Heart and Mind™: A Patient Engagement Pathway for Parents and Their Caregiving Partners After a Major Fetal Anomaly Diagnosis

NCT05282368

COMPLETED NA

Go/No-Go Intervention for Weight Loss

NCT04624087

COMPLETED NA

Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans

NCT04259632

COMPLETED Phase 4

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

NCT04387136

COMPLETED Phase 3

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

NCT04546581

COMPLETED NA

Identifying Body Awareness-related Brain Network Changes During Cognitive Multisensory Rehabilitation for Reduced Neuropathic Pain in People With Spinal Cord Injury

NCT04706208

COMPLETED NA

Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease

NCT04019379

COMPLETED NA

PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population

NCT04601493

COMPLETED NA

PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Primary Care Providers

NCT04601506

COMPLETED NA

PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population

NCT04601480

COMPLETED

Systemic Markers of Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical Periodontal Therapy

NCT04312542

COMPLETED NA

Effects of Prior Exposure to Conflicting Health Information on Responses to Subsequent Unrelated Health Messages

NCT04247529

COMPLETED NA

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

NCT04458181

COMPLETED Phase 1

The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever Vaccination

NCT04269265

COMPLETED

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

NCT04717492

COMPLETED

International SARS-CoV-2 (COVID-19) Infection Observational Study

NCT04385251

COMPLETED NA

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

NCT03927742

COMPLETED

The Professional Peer Resilience Initiative

NCT04396600

COMPLETED

Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)

NCT04339998

COMPLETED Phase 2

Losartan for Patients With COVID-19 Requiring Hospitalization

NCT04312009

COMPLETED Phase 2

Losartan for Patients With COVID-19 Not Requiring Hospitalization

NCT04311177

COMPLETED Phase 3

Pre-exposure Prophylaxis for SARS-Coronavirus-2

NCT04328467

COMPLETED Phase 1

Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment

NCT02967250

COMPLETED Phase 3

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

NCT04308668

COMPLETED NA

Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa

NCT04220112

COMPLETED

US and Neurodevelopmental Outcomes in the Neonatal Intensive Care Unit (NICU)

NCT05071508

TERMINATED NA

Influence of Exercise on the Gut Microbiome of Overweight and Obese Adults With Prediabetes

NCT04124354

COMPLETED Phase 4

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

NCT04177862

COMPLETED NA

Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic

NCT04761874

COMPLETED Phase 2

SMART Use of Medication for the Treatment of Adolescent Severe Obesity

NCT04007393

COMPLETED NA

Measurement of Glucose Metabolism in Humans: Effect of Recurrent Hypoglycemia on Hypothalamic GABA

NCT02829593

COMPLETED NA

Heated Humidification System Breathing Circuit for Maintenance of Body Temperature in Pediatric Patients

NCT03896867

COMPLETED

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

NCT03921658

COMPLETED NA

Neural Correlates of the Shift in Social Buffering of Social Evaluative Threat

NCT04211155

COMPLETED NA

Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy

NCT03195868

COMPLETED Phase 1

Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans

NCT04032301

COMPLETED NA

Care to Plan: a Tailored Resource for Family Members of Persons With Dementia

NCT03901456

TERMINATED NA

Chicory Fiber Effect on Satiety and GI Tolerance

NCT04067362

TERMINATED NA

Advanced Reperfusion Strategies for Refractory Cardiac Arrest

NCT03880565

COMPLETED NA

Evaluation of Link for Equity (School Staff Population)

NCT04026477

COMPLETED NA

Evaluation of Link for Equity (Students of Color Population)

NCT04026490

COMPLETED NA

Intra-Portal Alone Versus Intra- and Extra-Portal Transplantation of Pancreatic Islets After Total Pancreatectomy for Chronic Pancreatitis

NCT03779139

← Previous Page 8 of 20 Next →

Phase Distribution

PhaseTrial count
Phase 1 123
Phase 2 83
Phase 3 35
Phase 4 36

What is open in the University of Minnesota pipeline

180 recruiting of 966 indexed (19% open); 671 completed (69%).

Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).

Top condition: Obesity (14 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Minnesota: open-pipeline peers nationwide

Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20% Total trials Recruiting share University of MinnesotaColumbia UniversityBrigham and Women's HospitalHoffmann-La RocheBristol-Myers SquibbUniversity of Alabama at BirminghamMclean HospitalChildren's Hospital Medical Center, CincinnatiArkansas Children's Hospital Research Institute
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 966 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Minnesota page

966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.

  • 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.